Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.

Spence CD, Vanaudenaerde B, Einarsson GG, Mcdonough J, Lee AJ, Johnston E, Verleden GM, Elborn JS, Dupont LJ, Van Herck A, Gilpin DF, Vos R, Tunney MM, Verleden SE.

J Heart Lung Transplant. 2019 Nov 21. pii: S1053-2498(19)31759-0. doi: 10.1016/j.healun.2019.11.007. [Epub ahead of print]

PMID:
31812487
2.

Airway morphometry in COPD with bronchiectasis: a view on all airway generations.

Everaerts S, McDonough JE, Verleden SE, Josipovic I, Boone M, Dubbeldam A, Mathyssen C, Serré J, Dupont LJ, Gayan-Ramirez G, Verschakelen J, Hogg JC, Verleden GM, Vanaudenaerde BM, Janssens W.

Eur Respir J. 2019 Nov 7;54(5). pii: 1802166. doi: 10.1183/13993003.02166-2018. Print 2019 Nov.

PMID:
31467117
3.

Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.

Van Herck A, Frick AE, Schaevers V, Vranckx A, Verbeken EK, Vanaudenaerde BM, Sacreas A, Heigl T, Neyrinck AP, Van Raemdonck D, Dupont LJ, Yserbyt J, Verleden SE, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Mar;38(3):252-259. doi: 10.1016/j.healun.2018.12.006. Epub 2018 Dec 14.

PMID:
30686699
4.

Montelukast in chronic lung allograft dysfunction after lung transplantation.

Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM; Leuven Lung Transplant Group.

J Heart Lung Transplant. 2019 May;38(5):516-527. doi: 10.1016/j.healun.2018.11.014. Epub 2018 Dec 6.

PMID:
30638839
5.

Validation of a post-transplant chronic lung allograft dysfunction classification system.

Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Feb;38(2):166-173. doi: 10.1016/j.healun.2018.09.020. Epub 2018 Oct 4.

PMID:
30391199
6.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Dec;18(12):3045-3059. doi: 10.1111/ajt.15019. Epub 2018 Aug 17.

7.

AQUA© Questionnaire as prediction tool for atopy in young elite athletes.

Jonckheere AC, Seys SF, Dilissen E, Marijsse G, Schelpe AS, Van der Eycken S, Verhalle T, Vanbelle V, Aertgeerts S, Troosters T, Peers K, Dupont LJ, Bullens DMA.

Pediatr Allergy Immunol. 2018 Sep;29(6):648-650. doi: 10.1111/pai.12949. Epub 2018 Jul 9. No abstract available.

PMID:
29908073
8.

The aging lung: tissue telomere shortening in health and disease.

Everaerts S, Lammertyn EJ, Martens DS, De Sadeleer LJ, Maes K, van Batenburg AA, Goldschmeding R, van Moorsel CHM, Dupont LJ, Wuyts WA, Vos R, Gayan-Ramirez G, Kaminski N, Hogg JC, Janssens W, Verleden GM, Nawrot TS, Verleden SE, McDonough JE, Vanaudenaerde BM.

Respir Res. 2018 May 11;19(1):95. doi: 10.1186/s12931-018-0794-z.

9.

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.

Ruttens D, Verleden SE, Demeyer H, Van Raemdonck DE, Yserbyt J, Dupont LJ, Vanaudenaerde BM, Vos R, Verleden GM.

PLoS One. 2018 Apr 6;13(4):e0193564. doi: 10.1371/journal.pone.0193564. eCollection 2018.

10.

Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers.

Steelant B, Hox V, Van Gerven L, Dilissen E, Dekimpe E, Kasran A, Aertgeerts S, Van Belle V, Peers K, Dupont LJ, Hellings PW, Bullens DM, Seys SF.

Rhinology. 2018 Sep 1;56(3):279-287. doi: 10.4193/Rhin17.167.

PMID:
29561921
11.

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.

Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Mol Sci. 2018 Feb 9;19(2). pii: E523. doi: 10.3390/ijms19020523.

12.

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD.

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 31;12:2629-2638. doi: 10.2147/COPD.S141695. eCollection 2017.

13.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790
14.

High-dose vitamin D after lung transplantation: A randomized trial.

Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Van Herck A, Sacreas A, Heigl T, Schaevers V, Van Raemdonck DE, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Vanaudenaerde BM, Verleden GM.

J Heart Lung Transplant. 2017 Aug;36(8):897-905. doi: 10.1016/j.healun.2017.03.008. Epub 2017 Mar 8.

PMID:
28365177
15.

Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.

Seys SF, Scheers H, Van den Brande P, Marijsse G, Dilissen E, Van Den Bergh A, Goeminne PC, Hellings PW, Ceuppens JL, Dupont LJ, Bullens DM.

Respir Res. 2017 Feb 23;18(1):39. doi: 10.1186/s12931-017-0524-y.

16.

Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study.

De Soyza A, McDonnell MJ, Goeminne PC, Aliberti S, Lonni S, Davison J, Dupont LJ, Fardon TC, Rutherford RM, Hill AT, Chalmers JD.

Chest. 2017 Jun;151(6):1247-1254. doi: 10.1016/j.chest.2016.12.024. Epub 2017 Jan 16.

17.

End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.

Lammertyn EJ, Vandermeulen E, Bellon H, Everaerts S, Verleden SE, Van Den Eynde K, Bracke KR, Brusselle GG, Goeminne PC, Verbeken EK, Vanaudenaerde BM, Dupont LJ.

Respir Res. 2017 Jan 10;18(1):10. doi: 10.1186/s12931-016-0489-2.

18.

Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD.

Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16.

19.

Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis.

Van de Kerkhove C, Goeminne PC, Kicinski M, Nawrot TS, Lorent N, Van Bleyenbergh P, De Boeck K, Dupont LJ.

J Cyst Fibros. 2016 Nov;15(6):802-808. doi: 10.1016/j.jcf.2016.09.002. Epub 2016 Oct 5.

20.

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.

McDonnell MJ, Aliberti S, Goeminne PC, Dimakou K, Zucchetti SC, Davidson J, Ward C, Laffey JG, Finch S, Pesci A, Dupont LJ, Fardon TC, Skrbic D, Obradovic D, Cowman S, Loebinger MR, Rutherford RM, De Soyza A, Chalmers JD.

Thorax. 2016 Dec;71(12):1110-1118. doi: 10.1136/thoraxjnl-2016-208481. Epub 2016 Aug 11.

21.

Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.

Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Dubbeldam A, De Wever W, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM, Benden C, Vos R.

J Heart Lung Transplant. 2016 Sep;35(9):1078-84. doi: 10.1016/j.healun.2016.03.022. Epub 2016 Apr 16.

PMID:
27212563
22.

Long-term survival after lung transplantation among cystic fibrosis patients: Moving away from mere palliation.

Vos R, Verleden GM, Dupont LJ.

J Heart Lung Transplant. 2016 Jun;35(6):837-40. doi: 10.1016/j.healun.2016.01.011. Epub 2016 Jan 15. No abstract available.

PMID:
26948564
23.

Feasibility to apply eucapnic voluntary hyperventilation in young elite athletes.

Van der Eycken S, Schelpe A, Marijsse G, Dilissen E, Troosters T, Vanbelle V, Aertgeerts S, Dupont LJ, Peers K, Bullens DM, Seys SF.

Respir Med. 2016 Feb;111:91-3. doi: 10.1016/j.rmed.2015.12.012. Epub 2016 Jan 4.

24.

Morphometric Analysis of Explant Lungs in Cystic Fibrosis.

Boon M, Verleden SE, Bosch B, Lammertyn EJ, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens HA, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Van Raemdonck DE, Decramer M, Verleden GM, Hogg JC, Dupont LJ, Vanaudenaerde BM, De Boeck K.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):516-26. doi: 10.1164/rccm.201507-1281OC.

PMID:
26551917
25.

Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience.

Yserbyt J, Dooms C, Vos R, Dupont LJ, Van Raemdonck DE, Verleden GM.

Eur J Cardiothorac Surg. 2016 Jan;49(1):e1-8. doi: 10.1093/ejcts/ezv363. Epub 2015 Oct 13.

PMID:
26464447
26.

Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.

Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM, Somers J, Schoonis A, Schaevers V, Van Raemdonck DE, Neyrinck A, Dupont LJ, Yserbyt J, Verleden GM, Vos R.

Am J Transplant. 2016 Jan;16(1):254-61. doi: 10.1111/ajt.13417. Epub 2015 Aug 4.

27.

Combined or Serial Liver and Lung Transplantation for Epithelioid Hemangioendothelioma: A Case Series.

Desie N, Van Raemdonck DE, Ceulemans LJ, Nevens F, Verslype C, Vansteenbergen W, Pirenne J, Monbaliu D, Roskams T, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Verleden GM, Vos R.

Am J Transplant. 2015 Dec;15(12):3247-54. doi: 10.1111/ajt.13430. Epub 2015 Aug 19.

28.

BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.

Vandermeulen E, Verleden SE, Ruttens D, Moelants E, Mortier A, Somers J, Bellon H, Piloni D, Dupont LJ, Van Raemdonck DE, Proost P, Schols D, Vos R, Verleden GM, Vanaudenaerde BM.

Transpl Immunol. 2015 Sep;33(1):37-44. doi: 10.1016/j.trim.2015.07.001. Epub 2015 Jul 11.

PMID:
26168736
29.

Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis.

Goeminne PC, Nawrot TS, De Boeck K, Nemery B, Dupont LJ.

J Cyst Fibros. 2015 Nov;14(6):741-7. doi: 10.1016/j.jcf.2015.04.004. Epub 2015 May 2.

30.

An outbreak of swimming-pool related respiratory symptoms: An elusive source of trichloramine in a municipal indoor swimming pool.

Seys SF, Feyen L, Keirsbilck S, Adams E, Dupont LJ, Nemery B.

Int J Hyg Environ Health. 2015 Jun;218(4):386-91. doi: 10.1016/j.ijheh.2015.03.001. Epub 2015 Mar 10.

PMID:
25819556
31.

Role of genetics in lung transplant complications.

Ruttens D, Vandermeulen E, Verleden SE, Bellon H, Vos R, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden GM.

Ann Med. 2015 Mar;47(2):106-15. doi: 10.3109/07853890.2015.1004359. Epub 2015 Mar 13. Review.

PMID:
25766881
32.

Restrictive chronic lung allograft dysfunction: Where are we now?

Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Van Raemdonck DE, Dupont LJ, Vanaudenaerde BM, Verleden G, Vos R.

J Heart Lung Transplant. 2015 May;34(5):625-30. doi: 10.1016/j.healun.2014.11.007. Epub 2014 Nov 11.

PMID:
25577564
33.

Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation.

Vos R, Verleden SE, Ruttens D, Vandermeulen E, Bellon H, Neyrinck A, Van Raemdonck DE, Yserbyt J, Dupont LJ, Verbeken EK, Moelants E, Mortier A, Proost P, Schols D, Cox B, Verleden GM, Vanaudenaerde BM.

Am J Transplant. 2014 Dec;14(12):2736-48. doi: 10.1111/ajt.12942. Epub 2014 Nov 13.

34.

Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers.

Seys SF, Hox V, Van Gerven L, Dilissen E, Marijsse G, Peeters E, Dekimpe E, Kasran A, Aertgeerts S, Troosters T, Vanbelle V, Peers K, Ceuppens JL, Hellings PW, Dupont LJ, Bullens DM.

Allergy. 2015 Feb;70(2):187-94. doi: 10.1111/all.12540.

PMID:
25358760
35.

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJ, O'Dochartaigh C, van Haren EH, Vidal LO, Welte T, Fox HG, Wu J, Charlton B; B-305 Study Investigators.

Thorax. 2014 Dec;69(12):1073-9. doi: 10.1136/thoraxjnl-2014-205587. Epub 2014 Sep 21.

PMID:
25246664
36.

Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis.

Goeminne PC, Bijnens E, Nemery B, Nawrot TS, Dupont LJ.

Respir Res. 2014 Sep 3;15:108. doi: 10.1186/s12931-014-0108-z.

37.

IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease.

Peetermans M, Goeminne P, De Boeck C, Dupont LJ.

Chest. 2014 Sep;146(3):e99-e100. doi: 10.1378/chest.14-0635. No abstract available.

PMID:
25180753
38.

Low cord blood Foxp3/CD3γ mRNA ratios: a marker of increased risk for allergy development.

Bullens DM, Seys S, Kasran A, Dilissen E, Dupont LJ, Ceuppens JL.

Clin Exp Allergy. 2015 Jan;45(1):232-7. doi: 10.1111/cea.12389.

PMID:
25113399
39.

Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern.

Marijsse GS, Seys SF, Schelpe AS, Dilissen E, Goeminne P, Dupont LJ, Ceuppens JL, Bullens DM.

Am J Respir Crit Care Med. 2014 May 15;189(10):1284-5. doi: 10.1164/rccm.201311-2011LE. No abstract available.

PMID:
24832749
40.

Attentional modulation of reflex cough.

Janssens T, Silva M, Davenport PW, Van Diest I, Dupont LJ, Van den Bergh O.

Chest. 2014 Jul;146(1):135-141. doi: 10.1378/chest.13-2536.

PMID:
24556807
41.

Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure.

Boon M, Smits A, Cuppens H, Jaspers M, Proesmans M, Dupont LJ, Vermeulen FL, Van Daele S, Malfroot A, Godding V, Jorissen M, De Boeck K.

Orphanet J Rare Dis. 2014 Jan 22;9:11. doi: 10.1186/1750-1172-9-11.

42.

Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.

Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ.

Respir Med. 2014 Feb;108(2):287-96. doi: 10.1016/j.rmed.2013.12.015. Epub 2014 Jan 8.

43.

The bronchiectasis severity index. An international derivation and validation study.

Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT.

Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. doi: 10.1164/rccm.201309-1575OC.

44.

The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis.

Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ.

Respirology. 2014 Feb;19(2):203-210. doi: 10.1111/resp.12219. Epub 2013 Nov 29.

45.

Pirfenidone: a potential new therapy for restrictive allograft syndrome?

Vos R, Verleden SE, Ruttens D, Vandermeulen E, Yserbyt J, Dupont LJ, Van Raemdonck DE, De Raedt N, Gheysens O, De Jong PA, Verleden GM, Vanaudenaerde BM.

Am J Transplant. 2013 Nov;13(11):3035-40. doi: 10.1111/ajt.12474. Epub 2013 Sep 18.

46.

Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma.

Seys SF, Grabowski M, Adriaensen W, Decraene A, Dilissen E, Vanoirbeek JA, Dupont LJ, Ceuppens JL, Bullens DM.

Clin Exp Allergy. 2013 Sep;43(9):1009-17. doi: 10.1111/cea.12125.

PMID:
23957336
47.

Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).

Verleden SE, Vandermeulen E, Ruttens D, Vos R, Vaneylen A, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM, Verleden GM.

Semin Respir Crit Care Med. 2013 Jun;34(3):352-60. doi: 10.1055/s-0033-1348463. Epub 2013 Jul 2. Review.

PMID:
23821509
48.

Effects of high altitude and cold air exposure on airway inflammation in patients with asthma.

Seys SF, Daenen M, Dilissen E, Van Thienen R, Bullens DM, Hespel P, Dupont LJ.

Thorax. 2013 Oct;68(10):906-13. doi: 10.1136/thoraxjnl-2013-203280. Epub 2013 Jul 2.

PMID:
23821393
49.

The effect of gastric juice on interleukin-8 production by cystic fibrosis primary bronchial epithelial cells.

Pauwels A, Verleden S, Farre R, Vanaudenaerde BM, Van Raemdonck D, Verleden G, Sifrim D, Dupont LJ.

J Cyst Fibros. 2013 Dec;12(6):700-5. doi: 10.1016/j.jcf.2013.03.006. Epub 2013 Apr 20.

50.

Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?

Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Transplantation. 2013 May 15;95(9):1167-72. doi: 10.1097/TP.0b013e318286e076.

PMID:
23425818

Supplemental Content

Loading ...
Support Center